Recent Finacing
Recent Raise
Ocon Therapeutics develops, manufactures, and commercializes 3D intrauterine drug-delivery systems— including the spherical Ballerine copper IUB—and advances SEAD/PRIMA therapies for abnormal and heavy uterine bleeding in clinical trials.
